@article{d86be3829a82462197bc71d7233b78bd,
title = "Allergic airway recall responses require IL-9 from resident memory CD4+ T cells",
abstract = "Asthma is a chronic inflammatory lung disease with intermittent flares predominately mediated through memory T cells. Yet, the identity of long-term memory cells that mediate allergic recall responses is not well defined. In this report, using a mouse model of chronic allergen exposure followed by an allergen-free rest period, we characterized a subpopulation of CD4+ T cells that secreted IL-9 as an obligate effector cytokine. IL-9–secreting cells had a resident memory T cell phenotype, and blocking IL-9 during a recall challenge or deleting IL-9 from T cells significantly diminished airway inflammation and airway hyperreactivity. T cells secreted IL-9 in an allergen recall–specific manner, and secretion was amplified by IL-33. Using scRNA-seq and scATAC-seq, we defined the cellular identity of a distinct population of T cells with a proallergic cytokine pattern. Thus, in a recall model of allergic airway inflammation, IL-9 secretion from a multicytokine-producing CD4+ T cell population was required for an allergen recall response.",
author = "Ulrich, {Benjamin J.} and Rakshin Kharwadkar and Michelle Chu and Abigail Pajulas and Charanya Muralidharan and Byunghee Koh and Yongyao Fu and Hongyu Gao and Hayes, {Tristan A.} and Zhou, {Hong Ming} and Goplen, {Nick P.} and Nelson, {Andrew S.} and Yunlong Liu and Linnemann, {Amelia K.} and Turner, {Matthew J.} and Paula Licona-Lim{\'o}n and Flavell, {Richard A.} and Jie Sun and Kaplan, {Mark H.}",
note = "Funding Information: This work was supported by Public Health Service grants from the National Institutes of Health (R01 AI057459 and AI129241 to M.H.K.). B.J.U. was supported by National Institutes of Health grants T32 AI060519 and F30 HL147515. A.P. was supported by National Institutes of Health grant T32 AI060519. M.J.T. was supported by Veteran Affairs grants (CX001019 and CX002141). J.S. was supported by Public Health Service grants from the National Institutes of Health (AG069264 and AI147394). Core facility usage was also supported by Indiana University Simon Cancer Center Support grants P30 CA082709 and U54 DK106846 from the National Institutes of Health. Support provided by the Herman B Wells Center for Pediatric Research was, in part, from the Riley Children{\textquoteright}s Foundation. This project was supported by the Indiana Clinical and Translational Sciences Institute, funded in part by award number UL1TR002529 from the National Institutes of Health, National Center for Advancing Translational Sciences, and Clinical and Translational Sciences Award. This work was supported by the Brown Center for Immunotherapy. Publisher Copyright: Copyright {\textcopyright} 2022 The Authors, some rights reserved;",
year = "2022",
month = mar,
doi = "10.1126/SCIIMMUNOL.ABG9296",
language = "English (US)",
volume = "7",
journal = "Science immunology",
issn = "2470-9468",
publisher = "American Association for the Advancement of Science",
number = "69",
}